CompletedNot Applicable

Design and Application of Nasal Stents

China80 participantsStarted 2020-10-22

Plain-language summary

Comparative study of nasal stents and nasal packing in patients undergoing septoplasty

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. The subjects voluntarily participate in the experiment and sign the informed consent;
✓. Age range from 18 to 70 years old, gender unlimited;
✓. With nasal congestion as the chief complaint, CT of sinus suggested deviation of nasal septum with indications of surgery (deviation of nasal septum affects breathing and nasal congestion is serious; High nasal septum deviation affects sinus drainage or causes reflex headache; Nasal septum spine often causes nasal bleeding; Nasal septum deviation affects eustachian tube function);
✓. No history of respiratory tract infection and nasal decongestant use within 1 month before the visit;
✓. No other treatment was used;
✓. ASA grade 1\~2;
✓. Able to communicate well with researchers and follow the requirements of the experiment.

✕. There are acute and chronic rhinosinusitis, nasal polyps, benign and malignant tumors and other nasal diseases;
✕. History of craniocerebral and nasal surgery;
✕. The results of preoperative coagulation function test exceeded 20% of the upper limit of normal value;
✕. Patients known to be allergic to test instrument materials;
✕. Pregnant or lactating women;
✕. Other organoplastic or functional diseases complicated by the subjects limited their participation in the study and could not comply with the follow-up or affect the scientific integrity of the study;
✕. Participants who have participated in other clinical trials within the last 1 month;
✕. Participants considered unsuitable for this clinical trial for other reasons.

Effective rate of packing

Timeframe: 2days after operation

NCT IDNCT05243147

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-30

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. The subjects voluntarily participate in the experiment and sign the informed consent;
✓. Age range from 18 to 70 years old, gender unlimited;
✓. With nasal congestion as the chief complaint, CT of sinus suggested deviation of nasal septum with indications of surgery (deviation of nasal septum affects breathing and nasal congestion is serious; High nasal septum deviation affects sinus drainage or causes reflex headache; Nasal septum spine often causes nasal bleeding; Nasal septum deviation affects eustachian tube function);
✓. No history of respiratory tract infection and nasal decongestant use within 1 month before the visit;
✓. No other treatment was used;
✓. ASA grade 1\~2;
✓. Able to communicate well with researchers and follow the requirements of the experiment.

✕. There are acute and chronic rhinosinusitis, nasal polyps, benign and malignant tumors and other nasal diseases;
✕. History of craniocerebral and nasal surgery;
✕. The results of preoperative coagulation function test exceeded 20% of the upper limit of normal value;
✕. Patients known to be allergic to test instrument materials;
✕. Pregnant or lactating women;
✕. Other organoplastic or functional diseases complicated by the subjects limited their participation in the study and could not comply with the follow-up or affect the scientific integrity of the study;
✕. Participants who have participated in other clinical trials within the last 1 month;
✕. Participants considered unsuitable for this clinical trial for other reasons.